Role of immune response in Yersinia pestis infection

Journal of Infection in Developing Countries

Volumn 5, Issue 9, 2011, Pages 628-639

  Amedei, Amedeo ^a,b   Niccolai, Elena ^a   Marino, Luigi ^a   D'Elios, Mario M ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Adaptive immunity; Innate immunity; Yersinia pestis

Indexed keywords

LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; ANTIBODY COMBINING SITE; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; APOPTOSIS; B LYMPHOCYTE; CELLULAR IMMUNITY; COMPLEMENT INHIBITION; CYTOKINE RELEASE; DENDRITIC CELL; HISTOCOMPATIBILITY COMPLEX; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INNATE IMMUNITY; LYSIS; NATURAL KILLER CELL; PHAGOCYTOSIS; PLAGUE; PROTEIN INDUCTION; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINATION;

BACTERIA (MICROORGANISMS); RODENTIA; SIPHONAPTERA (FLEAS); YERSINIA PESTIS;

EID: 80052937790     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.1999     Document Type: Review

References (87)

1. Yersin A (1894) La peste bubonique a Hong Kong. Ann Inst Pasteur (Paris) 8: 662-667.
2. Simond P (1898) La propagation de la Peste. Ann Inst Pasteur (Paris) 12: 625.
3. Christie AB and Corbel MJ (1990) Plague and other yersinial diseases. In Smith GR and Easmon CSF, editors. Bacterial Diseases, 8th edition. London: Edward Arnold. 399-421.
4. Perry RD and Fetherston JD (1997) Yersinia pestis: etiologic agent of plague. Clin Microbiology Rev 10: 35-66.
5. Scott S and Duncan C (2001) Biology of plagues: evidence from historical populations. Cambridge: Cambridge University Press. pp. 125-135.
6. World Health Organization (2003) Human plague in 2000 and 2001. Wkly Epidemiol Rec 78: 130-35.
7. Migliani R (2003) La peste humaine a Madagascar, 45 annees de surveillance de 1957 a 2001. DEA Sante publique et pays en developpement: Universite Pierre et Marie Curie (Paris VI).
8. Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Koerner JF, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Schoch-Spana M, Tonat K (2000) Plague as a biological weapon: medical and public health management. Working group on civilian biodefense. JAMA 283: 2281-2290.
9. Ratsitorahina M, Chanteau S, Rahalison L, Ratsifasoamanana L, Boisier P (2000) Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar. Lancet 355: 111-113.
10. Prentice MB and Rahalison L (2007) Plague. Lancet 369: 1196-1207.
11. Hinnebusch BJ, Rudolph AE, Cherepanov P, Dixon JE, Schwan TG, Forsberg A (2002) Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vector. Science 296: 733-755.
12. Lathem WW, Price PA, Miller VL, Goldman WE (2007) A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science 315: 509-513.
13. Dennis DT, Gage KL, Gratz N, Poland JD, Tikhomirov E (1999) Plague Manual: Epidemiology, Distribution, Surveillance and Control. Wkly Epidemiol Rec 74: 447.
14. Prentice MB and Rahalison L (2007) Plague. Lancet 369: 1196-1207.
15. Broussard LA (2001) Biological agents: weapons of warfare and bioterrorism. Mol Diagn 6: 323-333.
16. Dennis DT (2005) Plague as a biological weapon. In Fong IW and Alibek K, editors. Bioterrorism and infectious agents: a new dilemma for the 21st century. Springer Science: 37-64.
17. Welch TJ, Fricke WF, McDermott PF, White DG, Rosso ML, Rasko DA, Mammel MK, Eppinger M, Rosovitz MJ, Wagner D, Rahalison L, Leclerc JE, Hinshaw JM, Lindler LE, Cebula TA, Carniel E, Ravel J (2007) Multiple antimicrobial resistance in plague: an emerging public health risk. PLoS ONE 2:e309.
18. Elvin SJ, Williamson ED, Scott JC, Smith JN, Perez De Lema G, Chilla S, Clapham P, Pfeffer K, Schlondorff D, Luckow B (2004) Evolutionary genetics: ambiguous role of CCR5 in Yersinia pestis infection. Nature 430: 417.
19. Takahashi K and Kawai T (2007) Pathogen recognition by Toll-like receptor. Nippon Rinsho 65: 53-57.
20. Miller SI, Ernst RK, Bader MW (2005) LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 3: 36-46.
21. Rebeil R, Ernst RK, Jarrett CO, Adams KN, Miller SI, Hinnebusch BJ (2006) Characterization of late acyltransferase genes of Yersinia pestis and their role in temperature-dependent lipid A variation. J Bacteriol 188: 1381-1388.
22. Montminy SW, Khan N, McGrath S, Walkowicz MJ, Sharp F, Conlon JE, Fukase K, Kusumoto S, Sweet C, Miyake K, Akira S, Cotter RJ, Goguen JD, Lien E (2006) Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat Immunol 7: 10660-1073.
23. Une T and Brubaker RR (1984) In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of yersiniae. Infect Immun 43: 895-900.
24. Anisimov AP, Dentovskaya SV, Titareva GM, Bakhteeva IV, Shaikhutdinova RZ, Balakhonov SV, Lindner B, Kocharova NA, Senchenkova SN, Holst O, Pier GB, Knirel YA (2005) Intraspecies and temperature-dependent variations in susceptibility of Yersinia pestis to the bactericidal action of serum and to polymyxin B. Infect Immun 73: 7324-7331.
25. Bartra SS, Styer KL, O'Bryant DM, Nilles ML, Hinnebusch BJ, Aballay A, Plano GV (2008) Resistance of Yersinia pestis to complementdependent killing is mediated by the Ail outer membrane protein. Infect Immun 76: 612-622.
26. Lukaszewski RA, Kenny DJ, Taylor R, Rees DG, Hartley MG, Oyston PC (2005) Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils. Infect Immun 73: 7142-7150.
27. Pujol C and Bliska JB (2003) The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis. Infect Immun 71: 5892-5899.
28. Zhou D, Han Y, Yang R (2006) Molecular and physiological insights into plague transmission, virulence, and etiology. Microbes Infect 8: 273-284.
29. Oyston PC, Dorrell N, Williams K, Li SR, Green M, Titball RW, Wren BW (2000) The response regulator PhoP is important for survival under conditions of macrophage- induced stress and virulence in Yersinia pestis. Infect Immun 68: 3419-3425.
30. Du Y, Rosqvist R, Forsberg A (2002) Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect Immun 70: 1453-1460.
31. Price SB, Freeman MD, Yeh KS (1995) Transcriptional analysis of the Yersinia pestis pH 6 antigen gene. J Bacteriol 177: 5997-6000.
32. Makoveichuk E, Cherepanov P, Lundberg S, Forsberg A, Olivecrona G (2003) pH6 antigen of Yersinia pestis interacts with plasma lipoproteins and cell membranes. J Lipid Res 44: 320-330.
33. Cornelis GR (2002) The Yersinia Ysc-Yop virulence apparatus. Int J Med Microbiol 291: 455-462.
34. Navarro L, Alto NM, Dixon JE (2005) Functions of the Yersinia effector proteins in inhibiting host immune responses. Curr Opin Microbiol 8: 21-27.
35. Kerschen EJ, Cohen DA, Kaplan AM, Straley SC (2004) The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect Immun 72: 4589-4602.
36. Iriarte M and Cornelis GR (1998) YopT, a new Yersinia Yop effector protein, affects the cytoskeleton of host cells. Mol Microbiol 29: 915-929.
37. Rosqvist R, Forsberg A, Rimpilainen M, Bergman T, Wolf-Watz H (1990) The cytotoxic protein YopE of Yersinia obstructs the primary host defense. Mol Microbiol 4: 657-667.
38. Leung KY, Reisner BS, Straley SC (1990) YopM inhibits platelet aggregation and is necessary for virulence of Yersinia pestis in mice. Infect Immun. 58: 3262-3271.
39. Mulder B, Michiels T, Simonet M, Sory MP, Cornelis G (1989). Identification of additional virulence determinants on the pYV plasmid of Yersinia enterocolitica W227. Infect Immun. 57: 2534-2541.
40. Green SP, Hartland EL, Robins-Browne RM, Phillips WA (1995) Role of YopH in the suppression of tyrosine phosphorylation and respiratory burst activity in murine macrophages infected with Yersinia enterocolitica. J Leukoc Biol 57: 972-977.
41. Kerschen EJ, Cohen DA, Kaplan AM, Straley SC (2004) The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect Immun. 72: 4589-4602.
42. Skrzypek E, Cowan C, Straley SC (1998) Targeting of the Yersinia pestis YopM protein into HeLa cells and intracellular trafficking to the nucleus. Mol Microbiol. 30: 1051-1065.
43. Boland A and Cornelis GR (1998) Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection. Infect Immun 66: 1878-1884.
44. McDonald C, Vacratsis PO, Bliska JB, Dixon JE (2003) The yersinia virulence factor YopM forms a novel protein complex with two cellular kinases. J Biol Chem 278: 18514-18523.
45. Pettersson J, Holmstrom A, Hill J, Leary S, Frithz-Lindsten E, von Euler-Matell A, Carlsson E, Titball R, Forsberg A, Wolf-Watz H (1999) The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol Microbiol 32: 961-976.
46. Sing A, Rost D, Tvardovskaia N, Roggenkamp A, Wiedemann A, Kirschning CJ, Aepfelbacher M, Heesemann J (2002) Yersinia V-antigen exploits Toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp Med 196: 1017-1024.
47. Overheim KA, Depaolo RW, Debord KL, Morrin EM, Anderson DM, Green NM, Brubaker RR, Jabri B, Schneewind O (2005) LcrV plague vaccine with altered immunomodulatory properties. Infect Immun 73: 5152-5159.
48. Denecker G, Totemeyer S, Mota LJ, Troisfontaines P, Lambermont I, Youta C, Stainier I, Ackermann M, Cornelis GR (2002) Effect of lowand high-virulence Yersinia enterocolitica strains on the inflammatory response of human umbilical vein endothelial cells. Infect Immun 70: 3510-3520.
49. Zhou D, Tong Z, Song Y, Han Y, Pei D, Pang X, Zhai J, Li M, Cui B, Qi Z, Jin L, Dai R, Du Z, Wang J, Guo Z, Huang P, Yang R (2004) Genetics of metabolic variations between Yersinia pestis biovars and the proposal of a new biovar, microtus. J Bacteriol 186: 5147-5152.
50. Welkos S, Friedlander A, McDowell D, Weeks J, Tobery S (1998) V antigen of Yersinia pestis inhibits neutrophil chemotaxis. Microb Pathog 24: 185-196.
51. Banchereau J, Steinman RM (1998). Dendritic cells and the control of immunity. Nature 392: 245-252.
52. Lee HK, Iwasaki A (2007) Innate control of adaptive immunity: dendritic cells and beyond. Semin Immunol 19: 48-55.
53. Marketon MM, DePaolo RW, DeBord KL, Jabri B, Schneewind O (2005) Plague bacteria target immune cells during infection. Science 309: 1739-1741.
54. Yao T, Mecsas J, Healy JI, Falkow S, Chien Y (1999) Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH. J Exp Med 190: 1343-1350.
55. Alonso A, Bottini N, Bruckner S, Rahmouni S, Williams S, Schoenberger SP, Mustelin T (2004) Lck dephosphorylation at Tyr-394 and inhibition of T-cell antigen receptor signaling by Yersinia phosphatase YopH. J Biol Chem 279: 4922-4928.
56. Salvesen GS, Mustelin T (2005) Yersinia phosphatase induces mitochondrially dependent apoptosis of T cells. J Biol Chem 280: 10388-10394.
57. Bruckner S, Rhamouni S, Tautz L, Denault JB, Alonso A, Becattini B, Salvesen GS, Mustelin T (2005) Yersinia phosphatase induces mitochondrially dependent apoptosis of T cells. J Biol Chem 280: 10388-10394.
58. Trulzsch K, Geginat G, Sporleder T, Ruckdeschel K, Hoffmann R, Heesemann J, Russmann H (2005) Yersinia outer protein P inhibits CD8 T-cell priming in the mouse infection model. J Immunol 174: 4244-4251.
59. Brubaker RR (2007) How the structural gene products of Yersinia pestis relate to virulence. Future Microbiol 2: 377-385.
60. Zauberman A, Cohen S, Mamroud E, Flashner Y, Tidhar A, Ber R, Elhanany E, Shafferman A, Velan B (2006) Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis. Infect Immun 74: 3239-3250.
61. Robinson WH (2006) Antigen arrays for antibody profiling. Curr Opin Chem Biol 10: 67-72.
62. Li B, Zhou D, Wang Z, Song Z, Wang H, Li M, Yang R (2008) Antibody profiling in plague patients by protein microarray. Microbes Infect 10: 45-51.
63. Leary SE, Griffin KF, Garmory HS, Williamson ED, Titball RW (1997) Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague. Microb Pathog 23: 167-179.
64. Simpson WJ, Thomas RE, Schwan TG (1990) Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice. Am J Trop Med Hyg 43: 389-396.
65. Williamson ED, Vesey PM, Gillhespy KJ, Eley SM, Green M, Titball RW (1999) An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin Exp Immunol 116: 107-114.
66. Matson JS, Durick KA, Bradley DS, Nilles ML (2005) Immunization of mice with YscF provides protection from Yersinia pestis infections. BMC Microbiol 5: 38.
67. Murphy BS, Wulff CR, Garvy BA, Straley SC (2007) Yersinia pestis YadC: a novel vaccine candidate against plague. Adv Exp Med Biol 603: 400-414.
68. Pitt ML (2004) Non-human primates as a model for pneumonic plague. Animals Models and Correlates of Protection for Plague Vaccines Workshop. Available: http://www.fda.gov/cber/minutes/plague101304t.pdf.
69. Del Prete G, Santi L, Andrianaivoarimanana V, Amedei A, Domarle O, D'Elios MM, Arntzen CJ, Rahalison L, Mason HS (2009) Plant-derived recombinant F1, V, and F1-V fusion antigens of Yersinia pestis activate human cells of the innate and adaptive immune system. Int J Immunopathol Pharmacol 22: 133-143.
70. Elvin SJ, Williamson ED (2004) Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague. Microb Pathog 37: 177-184.
71. Parent MA, Berggren KN, Kummer LW, Wilhelm LB, Szaba FM, Mullarky IK, Smiley ST (2005) Cell-mediated protection against pulmonary Yersinia pestis infection. Infect Immun 73: 7304-7310.
72. Philipovskiy AV and Smiley ST (2007) Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection. Infect Immun 75: 878-885.
73. Haq TA, Mason HS, Clements JD, Arntzen CJ (1995) Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268: 714-716.
74. Mason HS, Haq TA, Clements JD, Arntzen CJ (1998) Edible vaccine protects mice against Escherichia coli heat- labile enterotoxin (LT): potatoes expressing a synthetic LT- B gene. Vaccine 16: 1336-1343.
75. Marillonnet S, Thoeringer C, Kandzia R, Klimyuk V, Gleba Y (2005) Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nat Biotechnol 23: 718-723.
76. Gleba Y, Klimyuk V, Marillonnet S (2005) Magnifection- a new platform for expressing recombinant vaccines in plants. Vaccine 23: 2042-2048.
77. Santi L, Giritch A, Roy CJ, Marillonnet S, Klimyuk V, Gleba Y, Webb R, Arntzen CJ, Mason HS (2006) Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. Proc Natl Acad Sci USA 103: 861-866.
78. Burrows TW (1956) An antigen determining virulence in Pasteurella pestis. Nature 177: 426-427.
79. Brubaker RR (2003) Interleukin-10 and inhibition of innate immunity to Yersiniae: Roles of Yops and LcrV (V antigen). Infect Immun 71: 3673-3681.
80. Sing A, Reithmeier-Rost D, Granfors K, Hill J, Roggenkamp A, Heesemann J (2005) A hypervariable N- terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence. Proc Natl Acad Sci USA 102: 16049-16054.
81. Covert BA, Spencer JS, Orme IM, Belisle JT (2001) The application of proteomics in defining the T cell antigens of Mycobacterium tuberculosis. Proteomics. 1: 574-586.
82. Li B, Zhou L, Guo J, Wang X, Ni B, Ke Y, Zhu Z, Guo Z, Yang R (2009) High-throughput identification of new protective antigens from a Yersinia pestis live vaccine by enzyme-linked immunospot assay. Infect Immun 77: 4356-4361.
83. Sing A, Rost D, Tvardovskaia N, Roggenkamp A, Wiedemann A, Kirschning CJ, Aepfelbacher M, Heesemann J (2002) Yersinia V-antigen exploits Toll-like Receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J Exp Med 196: 1017-1024.
84. Reithmeier-Rost D, Bierschenk S, Filippova N, Schroder-Braunstein J, Sing A (2004) Yersinia V antigen induces both TLR homo- and heterotolerance in an IL-10-involving manner. Cell Immunol 231: 63-74.
85. Sing A, Tvardovskaia N, Rost D, Kirschning CJ, Wagner H, Heesemann J (2003) Contribution of Toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model. Int J Med Microbiol 293: 341-348.
86. Covert BA, Spencer JS, Orme IM, Belisle JT (2001) The application of proteomics in defining the T-cell antigens of Mycobacterium tuberculosis. Proteomics 1: 574-586.
87. Li B, Zhou L, Guo J, Wang X, Ni B, Ke Y, Zhu Z, Guo Z, Yang R (2009) High-throughput identification of new protective antigens from a Yersinia pestis live vaccine by enzyme-linked immunospot assay. Infect Immun 77: 4356-4361.